Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair

International Journal of Cardiovascular Imaging

Volumn 23, Issue 2, 2007, Pages 159-165

  Feringa, Harm H H ^a   Poldermans, Don ^b   Klein, Patrick ^a   Braun, Jerry ^a   Klautz, Robert J M ^a   van Domburg, Ron T ^b   van der Laarse, Arnoud ^a   van der Wall, Ernst E ^a   Dion, Robert A E ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Heart failure; Left ventricular function; Mitral valve repair; Natriuretic peptides

Indexed keywords

NATRIURETIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HEART WEIGHT; HUMAN; MALE; MITRAL VALVE REPLACEMENT; PROGNOSIS; PROTEIN BLOOD LEVEL;

EID: 33947232763     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-006-9138-z     Document Type: Article

References (14)

1. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328
2. Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257-260
3. Yoshimura M, Yasue H, Okumura K et al. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87:464-469
4. Yasue H, Yoshimura M, Sumida H et al. (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195-203
5. Lainchbury JG, Campbell E, Frampton CM et al. (2003) Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42:728-735
6. Gardner RS, Ozalp F, Murday AJ et al. (2003) N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24:1735-1743
7. Bettencourt P, Azevedo A, Pimenta J et al. (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110:2168-2174
8. Nelson CA, Case C, McCrohon J et al. (2005) Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction. Int J Cardiovasc Imaging 21:295-302
9. Mayer SA, De Lemos JA, Murphy SA et al. (2004) Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol 93:1002-1006
10. Brookes CI, Kemp MW, Hooper J et al. (1997) Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 6:608-612
11. Sutton TM, Stewart RA, Gerber IL et al. (2003) Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 41:2280-2287
12. Thomas JD (1997) How leaky is that mitral valve? Simplified Doppler methods to measure regurgitant orifice area. Circulation 95:548-555
13. Yeo KT, Wu AH, Apple FS et al. (2003) Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338:107-115
14. Detaint D, Messika-Zeitoun D, Avierinos JF et al. (2005) B-type natriuretic peptide in organic mitral regurgitation: Determinants and impact on outcome. Circulation 111:2391-2397